Digital
What’s next for clinical data management?
The life sciences industry has seen its share of headwinds and tailwinds in recent years.
R&D
ASCO 2023 preview: Prioritising the exploration of patient d...
The American Society of Clinical Oncology (ASCO) annual meeting is approaching and provides the ideal setting to connect
Market Access
PM Society’s ‘Securing Market Access to Medicines for Englan...
On Tuesday afternoon, 23rd May, pharmaphorum headed over to The Royal Society of Medicine to learn more about how the pharmaceutical industry goes about securing market access to medicines
Market Access
Is net-zero an achievable target for pharma?
The pharmaceutical industry has arguably been slow to prioritise the environment and sustainable strategies.
Digital
Short-term crucial to future of AI drug discovery
One of the lead prospects in a new generation of AI-developed drug candidates struggled in late-stage trials.
Editor's Picks
Editor's Picks
